Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2010
09/10/2010CA2752443A1 Heterocyclic antiviral compounds
09/10/2010CA2751836A1 3-arylquinazolin-4-one compounds for combating invertebrate pests
09/10/2010CA2751534A1 Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators
09/10/2010CA2750862A1 Fungicidal pyrazoles
09/09/2010US20100228035 Functionalized Ionic Liquids, and Methods of Use Thereof
09/09/2010US20100228015 Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
09/09/2010US20100228008 Dyes linked to target molecules, oligonucleotides or polynucleotides comprising dye molecules, composite dyes and other compositions useful for detecting or quantifying desirable target molecules
09/09/2010US20100227894 Benzamide factor viia inhibitors useful as anticoagulants
09/09/2010US20100227892 Compounds, Compositions and Methods for Treatment and Prevention of Orthopoxvirus Infections and Associated Diseases
09/09/2010US20100227891 Threshold blood omeprazole concentration is 50 ng/ml for the maintenance of intragastric ph of at least 4.0 after oral dosing with cma-omeprazole, agn 201904-z
09/09/2010US20100227890 Polymorphs of esomeprazole salts
09/09/2010US20100227889 Benzimidazole Derivatives
09/09/2010US20100227887 Pyridine-2-yl carboxylic acid amides
09/09/2010US20100227866 Tetrahydroisoquinolin-1-one derivative or salt thereof
09/09/2010US20100227864 5-membered heterocyclic derivative and use thereof for medical purposes
09/09/2010US20100227863 Substituted 3-(4-hydroxyphenyl)-indolin-2-one compounds
09/09/2010US20100227860 Disalt inhibitors of il-12 production
09/09/2010US20100227855 Helix 12 directed non-steroidal antiandrogens
09/09/2010US20100227846 Substituted pyrazole derivative
09/09/2010US20100227331 Detection of immobilized nucleic acid
09/09/2010US20100226918 Pyrrole derivatives as p2y12 antagonists
09/09/2010US20100226883 Linked diimidazole derivatives
09/09/2010US20100226882 Linked diimidazole antivirals
09/09/2010US20100226879 Heterocyclic antiviral compounds
09/08/2010EP2226322A1 Imidazole carbonyl compound
09/08/2010EP2226315A1 2-aminoquinazoline derivative
09/08/2010EP2225231A1 Aminotriazole derivatives as alx agonists
09/08/2010EP2225226A1 Compounds and method for treatment of cancer
09/08/2010EP2225223A2 Organic compounds
09/08/2010EP2225222A1 A quinoline derivative acting as a p2x7-receptor antagonist
09/08/2010EP2225221A2 Carboxyl- or hydroxyl-substituted benzimidazole derivatives
09/08/2010EP2225211A1 Herbicidal pyridazinone derivatives
09/08/2010EP2081921B1 Short-acting benzodiazepine salts and their polymorphic forms
09/08/2010EP1841741B1 Piperidine derivatives as prodrugs of potassium channel inhibitors
09/08/2010EP1813610B1 Novel pyridonecarboxylic acid derivatives or salts thereof
09/08/2010EP1773811B1 A crystalline variable hydrate of (s)-6-(4-(2-((3-(9h-carbazol-4-yloxy)-2-hydroxypropyl)amino)-2-methylpropyl)phenoxy)-3-pyridinecarbox amide hemisuccinate salt
09/08/2010EP1478624B1 Chemical compounds
09/08/2010EP1382336B1 Use of the abc expression promotor pioglitazone for the treatment of arteriosclerosis obliterans
09/08/2010EP0882717B1 Nitrogenous heterocyclic compounds
09/08/2010CN1968929B Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments
09/08/2010CN1732154B Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
09/08/2010CN101827837A Condensed anthranilamide derivatives as insectisides
09/08/2010CN101827836A Trisubstituted 1,2,4-triazoles
09/08/2010CN101827828A 1, 2, 4 -triazole derivatives as serotonergic modulators
09/08/2010CN101824033A Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
09/08/2010CN101824029A Tyrosine kinase irreversible inhibitor and medicine composition and application thereof
09/08/2010CN101824028A Process for preparing lansoprazole
09/08/2010CN101824027A Polysubstituted tetrahydroquinoline derivative with optical activity and synthetic method and use thereof
09/08/2010CN101125865B Chiral ruthenium complex and application of the same used as antineoplastic
09/08/2010CN101099740B Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
09/08/2010CN101080403B Novel hydantoin derivatives as metalloproteinase inhibitors
09/08/2010CN101044123B Pyrimidine derivative fused with nonaromatic ring
09/08/2010CN101039911B Polymorph of N,N-diethyl-4-(3-fluorophenyl-piperidin-4-ylidene-methyl)-benzamide hydrochloride salt
09/07/2010US7790891 reduction reaction with sulfonic acid chloride in presence of basic agent; proton pump inhibitors
09/07/2010US7790761 alleviating vision defects, multiple sclerosis, neurodegenerative diseases, stroke, spinal cord injury, Alzheimer's disease, Parkinson's disease or pain, comprising administering sodium channel modulators comprising pyrazole or indazole derivatives, such as 3-(5'-Hydroxymethyl-2'-furyl)-1-benzylindazole
09/07/2010US7790755 Controlled release preparation
09/07/2010US7790754 such as (2R) N-((1R)-1-{5-[5-chloro-3-fluoro-2-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-3-fluoropyridin-2-yl}ethyl)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide, useful in the treatment or prevention of symptoms such as pain and inflammation; analgesics and antiinflammatory agents
09/07/2010US7790752 Indol-3-yl-carbonyl-azaspiro derivatives
09/07/2010US7790750 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
09/07/2010US7790748 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
09/07/2010US7790743 Modulators of cellular adhesion
09/07/2010US7790736 Dipeptidyl peptidase inhibitors
09/07/2010US7790734 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; anticancer agents; skin disorders
09/07/2010US7790726 chemokine receptor antagonists such as 6-Chloro-3-{2-[4-(4-chloro-3-methoxy-phenyl)-4-hydroxy-piperidin-1-yl]-2-oxo-ethyl}-3H-benzooxazol-2-one, having in vivo antiinflammatory activity
09/07/2010US7790725 Thiazolidine derivatives and medicinal use thereof
09/07/2010US7790723 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes
09/07/2010US7790720 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
09/07/2010US7790719 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
09/07/2010US7790716 fatty acid biosynthesis inhibitors such as E)-3-(6-aminopyridin-3-yl)-N-methyl-N-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)acrylamide, used fro the treatment of bacterial infections; antibiotics
09/07/2010US7790715 Organic compounds
09/07/2010US7790713 Inhibitors of interleukin-1β converting enzyme
09/07/2010US7790711 Inhibitors of 11β-Hydroxysteroid Dehydrogenase
09/07/2010US7790709 Heterocyclic compounds, methods of making them and their use in therapy
09/07/2010US7790704 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment
09/07/2010CA2539729C Isoquinolinone potassium channel inhibitors
09/07/2010CA2521081C Pyrimidin-4-one derivatives and their use as p38 kinase modulators
09/07/2010CA2512193C 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases
09/07/2010CA2179935C Novel dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof
09/02/2010WO2010099379A1 Jak kinase modulating quinazoline derivatives and methods of use thereof
09/02/2010WO2010099054A2 Soluble guanylate cyclase activators
09/02/2010WO2010098496A1 Process for producing tetrahydrotriazolopyridine derivative
09/02/2010WO2010098488A1 Aryl imidazole compounds and their use as beta amyloid production inhibitors
09/02/2010WO2010098351A1 Process for producing pyrrole compound
09/02/2010WO2010098332A1 Method for producing polycyclic compound and intermediate for same
09/02/2010WO2010098145A1 Oxyindole derivatives with motilin receptor agonistic activity
09/02/2010WO2010097583A1 Esomeprazole potassium polymorph and its preparation
09/02/2010WO2010097468A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010097373A1 Compounds for use as bradykinin b1 antagonists
09/02/2010WO2010097372A1 Compounds as bradykinin b1 antagonists
09/02/2010WO2010097367A1 Radiolabelled pde10 ligands
09/02/2010WO2010096854A1 Methods of modulating the activity of the mc3 and/or mc4 receptors and treatment of conditions related to these receptors
09/02/2010WO2010096853A1 Methods of modulating the activity of the mc1 receptor and treatment of conditions related to this receptor
09/02/2010WO2010079504A3 Stable r (+) -lansoprazole amine salt and a process for preparing the same
09/02/2010WO2010053861A3 Biologically active amides
09/02/2010WO2010044885A3 Soluble mtor complexes and modulators thereof
09/02/2010WO2009027614A3 Method for splitting omeprazole salts
09/02/2010US20100222592 Pyridone Derivative and Herbicide
09/02/2010US20100222591 New Compounds
09/02/2010US20100222576 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
09/02/2010US20100222394 Method for producing pyrazol-3-yl-benzamide derivative
1 ... 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 ... 1080